Onconova Therapeutics (ONTX) Starts Presentation at LD Micro Main Event
Onconova Therapeutics (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, the company has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in clinical trials and several active pre-clinical programs. Advanced clinical trials with its lead compound, rigosertib, are aimed at unmet medical needs of patients with myelodysplastic syndromes (MDS). For more information, visit the company's website at www.onconova.com.…